Literature DB >> 8210367

Combined CT arterial portography and CT hepatic angiography for evaluation of the hepatic resection candidate. Work in progress.

J L Chezmar1, M E Bernardino, S H Kaufman, R C Nelson.   

Abstract

PURPOSE: To determine whether the addition of computed tomographic (CT) angiography to CT arterial portography would improve lesion detection and heighten confidence in interpreting perfusion abnormalities.
MATERIALS AND METHODS: The two examinations were performed sequentially in 10 candidates for surgical resection of hepatic tumors. Arterial vascular access was obtained with bilateral punctures of the common femoral artery and selective placement of angiographic catheters in the hepatic artery and superior mesenteric artery (SMA). CT scans were obtained first during injection of contrast material into the SMA, followed by repeated imaging of the liver during injection of contrast material into the hepatic artery.
RESULTS: The procedure demonstrated, among other results, three additional lesions in two patients, a possibly nontumorous abnormality as tumorous in one, and a suspected tumorous abnormality as nontumorous in one. Suspected nontumorous abnormalities in four patients were confirmed at CT angiography.
CONCLUSION: These preliminary data support a trial of this technique in a larger population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8210367     DOI: 10.1148/radiology.189.2.8210367

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Computed tomography-guided transarterial chemoembolization as the initial therapy for hepatocellular carcinoma: experience of 75 cases in a single institute.

Authors:  Yoichi Okada; Hiroyasu Ina; Kazunori Kubota; Yoshiro Himeno; Toshihiko Wakita; Isamu Ohashi; Naoya Gomi; Tetsuo Yoshida; Sunao Mae; Tetsuya Irie
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

2.  Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography.

Authors:  Kazunori Kubota; Hiroyasu Ina; Yoichi Okada; Tetsuya Irie
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

3.  Radiological assessment of hepatic vein invasion by hepatocellular carcinoma using combined computed tomography hepatic arteriography and computed tomography arterial portography.

Authors:  Akihiro Nishie; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Masakazu Hirakawa; Yasuhiro Ushijima; Daisuke Kakihara; Daisuke Okamoto; Nobuhiro Fujita; Akinobu Taketomi; Kengo Yoshimitsu; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2010-07-27       Impact factor: 2.374

4.  Usefulness of Y-shaped sheaths in CT angiography for examination of liver tumors.

Authors:  Toru Ishikawa; Kazuo Higuchi; Tomoyuki Kubota; Kei-ichi Seki; Terasu Honma; Toshiaki Yoshida; Takeo Nemoto; Keiko Takeda; Tomoteru Kamimura
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

5.  Therapeutic results of computed-tomography-guided transcatheter arterial chemoembolization for local recurrence of hepatocellular carcinoma after initial transcatheter arterial chemoembolization: the results of 85 recurrent tumors in 35 patients.

Authors:  Mikio Tezuka; Keiji Hayashi; Yoichi Okada; Tetsuya Irie; Hiroyasu Ina
Journal:  Dig Dis Sci       Date:  2008-07-23       Impact factor: 3.199

6.  Detection of liver neoplasms: techniques and outcomes.

Authors:  R L Baron
Journal:  Abdom Imaging       Date:  1994 Jul-Aug

7.  Outcome of small liver nodules detected by computed tomographic angiography in patients with hepatocellular carcinoma.

Authors:  Hideki Ohnishi; Kohsaku Sakaguchi; Kazuhiro Nouso; Yoshiyuki Kobayashi; Shinichiro Nakamura; Hironori Tanaka; Yasuhiro Miyake; Bon Shoji; Shouta Iwadou; Yasushi Shiratori
Journal:  Hepatol Int       Date:  2010-07-25       Impact factor: 6.047

Review 8.  CT during arterial portography.

Authors:  P Soyer
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.